Hi-Tech Prosecution Underscores Need To Monitor Ingredient Suppliers
Executive Summary
The successful prosecution of Hi-Tech Pharmaceuticals for counterfeiting generic Rx drugs underscores the need for manufacturers to monitor ingredient suppliers and test raw materials, food and drug attorney Marc Ullman advises